Momentum was growing for a fresh look at the safety of Celebrex and other pain relievers as key researchers, a congressman and European regulators said they feared such drugs might raise the risk of heart problems like those blamed on the arthritis medicine Vioxx.
When Merck withdrew Vioxx, S&P lowered its outlook to negative from stable.
The e-mail and meeting notes also show that Dr. David Graham, an official in the FDA's Office of Drug Safety, is seeking to begin a study of the safety of Bextra and Mobic, two arthritis pills that are similar to Vioxx.
